Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin price-fixing settlement

This article was originally published in The Tan Sheet

Executive Summary

Jan. 15 hearing scheduled in D.C. federal court on fairness of proposed $50 mil. settlement by Merck KgaA and its affiliates of class action claims brought by direct purchasers of vitamins A, B, C, E, beta carotene, premixes. Judge Thomas Hogan preliminarily approved the settlement in September; opt-out deadline for companies who wish to exclude themselves is Dec. 9. Unlike earlier settlement involving seven defendants including Hoffman-LaRoche and BASF, Merck settlement amount is fixed and will not be reduced by the number of class members opting out. Remaining defendants in the class action, which is scheduled for trial March 12, include Sumitomo Chemical America, Tanabe USA, Lonza, Degussa-Huls, Reilly Industries, Nepera (1"The Tan Sheet" March 4, 2002, p. 11)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094806

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel